Akoya Biosciences, Inc. (AKYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 113.17M |
| Enterprise Value | 185.54M |
| P/E Ratio | -1.15 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0.79 |
| Price/Book Ratio | 8.39 |
| Enterprise/Revenue | 1.68 |
| Enterprise/EBITDA | -3.68 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
| Profit Margin | -0.68 |
| Operating Margin | -0.57 |
| Return On Assets | -0.44 |
| Return On Equity | -1.8 |
| Revenue | 81.67M |
| Revenue/Share | 1.65 |
| Gross Profit | 47.88M |
| EBITDA | -37.14M |
| Net Income | -55.37M |
| Diluted EPS | -1.12 |
| Total Cash | 27.54M |
| Total Cash/Share | 0.71 |
| Total Debt | 83.72M |
| Total Debt/Equity | 11.08 |
| Current Ratio | 2.61 |
| Book Value Per Share | 0.15 |
| 52-Week Change | -34.18 |
| 52-Week High | 3.42 |
| 52-Week Low | 0.93 |
| Moving Average 50 Days | 1.22 |
| Moving Average 200 Days | 2.04 |
| Average Volume | 582,118 |
| Shares Outstanding | 49.95M |
| % Held by Institutions | 25.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |